Synovus Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
DM
SCM
PC
Synovus Financial's PCRX Position: Q2 2020 in Review
Synovus Financial sold out of Pacira BioSciences (PCRX) in Q2 2020, closing a stake of 19 shares — an estimated $1K sold.
Synovus Financial first reported a position in PCRX in Q4 2014 and held it in 13 quarters. The position peaked at $16K in Q1 2015. 248 funds tracked by Wall St. Rank hold PCRX as of Q2 2020.
- Synovus Financial reported no remaining Pacira BioSciences position as of Q2 2020 after selling out during the quarter.
- Synovus Financial sold 19 Pacira BioSciences shares in Q2 2020, an estimated $1K.
- Synovus Financial first reported a position in Pacira BioSciences in Q4 2014 and held it in 13 quarters.
- Synovus Financial's Pacira BioSciences position peaked at $16K in Q1 2015.
- 248 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2020.
Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.